Literature DB >> 17475858

Transcription of a productively rearranged Ig VDJC alpha does not require the presence of HS4 in the IgH 3' regulatory region.

Buyi Zhang1, Adrienne Alaie-Petrillo, Maria Kon, Fubin Li, Laurel A Eckhardt.   

Abstract

V gene assembly, class switch recombination, and somatic hypermutation are gene-modifying processes essential to the development of an effective Ab response. If inappropriately applied, however, these processes can mediate genetic changes that lead to disease (e.g., lymphoma). A series of control elements within the Ig H chain (Igh) locus has been implicated in regulating these processes as well as in regulating IgH gene transcription. These include the intronic enhancer (Emu) and several elements at the 3' end of the locus (hs1,2, hs3a, hs3b, and hs4) known collectively as the 3' regulatory region. Although it is clear that the Emu plays a unique role in V gene assembly, it has not been established whether there are unique functions for each element within the 3' regulatory region. In earlier studies in mice and in mouse cell lines, pairwise deletion of hs3b and hs4 had a dramatic effect on both class switch recombination and IgH gene transcription; deletion of an element almost identical with hs3b (hs3a), however, yielded no discernible phenotype. To test the resulting hypothesis that hs4 is uniquely required for these processes, we induced the deletion of hs4 within a bacterial artificial chromosome transgene designed to closely approximate the 3' end of the natural Igh locus. When introduced into an Ig-secreting cell line, an Igalpha transcription unit within the bacterial artificial chromosome was expressed efficiently and the subsequent deletion of hs4 only moderately affected Igalpha expression. Thus, hs4 does not play a uniquely essential role in the transcription of a productively rearranged Ig VDJCalpha transcription unit.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475858      PMCID: PMC2724394          DOI: 10.4049/jimmunol.178.10.6297

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

1.  Beta-globin YAC transgenes exhibit uniform expression levels but position effect variegation in mice.

Authors:  R Alami; J M Greally; K Tanimoto; S Hwang; Y Q Feng; J D Engel; S Fiering; E E Bouhassira
Journal:  Hum Mol Genet       Date:  2000-03-01       Impact factor: 6.150

2.  Elucidation of IgH intronic enhancer functions via germ-line deletion.

Authors:  Thomas Perlot; Frederick W Alt; Craig H Bassing; Heikyung Suh; Eric Pinaud
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-26       Impact factor: 11.205

3.  B cell development under the condition of allelic inclusion.

Authors:  E Sonoda; Y Pewzner-Jung; S Schwers; S Taki; S Jung; D Eilat; K Rajewsky
Journal:  Immunity       Date:  1997-03       Impact factor: 31.745

4.  Transgenic analysis of a 100-kb human beta-globin cluster-containing DNA fragment propagated as a bacterial artificial chromosome.

Authors:  R M Kaufman; C T Pham; T J Ley
Journal:  Blood       Date:  1999-11-01       Impact factor: 22.113

5.  Chromatin architecture near a potential 3' end of the igh locus involves modular regulation of histone modifications during B-Cell development and in vivo occupancy at CTCF sites.

Authors:  Francine E Garrett; Alexander V Emelyanov; Manuel A Sepulveda; Patrick Flanagan; Sabrina Volpi; Fubin Li; Dmitry Loukinov; Laurel A Eckhardt; Victor V Lobanenkov; Barbara K Birshtein
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

6.  Cutting edge: Ig heavy chain 3' HS1-4 directs correct spatial position-independent expression of a linked transgene to B lineage cells.

Authors:  C Chauveau; E A Jansson; S Müller; M Cogné; S Pettersson
Journal:  J Immunol       Date:  1999-11-01       Impact factor: 5.422

7.  Sites that direct nuclear compartmentalization are near the 5' end of the mouse immunoglobulin heavy-chain locus.

Authors:  Qiaoxin Yang; Roy Riblet; Carl L Schildkraut
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

8.  Expression and regulation of immunoglobulin heavy chain gene transfected into lymphoid cells.

Authors:  M S Neuberger
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

9.  Regulation of IgH gene assembly: role of the intronic enhancer and 5'DQ52 region in targeting DHJH recombination.

Authors:  Roshi Afshar; Steven Pierce; Daniel J Bolland; Anne Corcoran; Eugene M Oltz
Journal:  J Immunol       Date:  2006-02-15       Impact factor: 5.422

10.  Class switching in B cells lacking 3' immunoglobulin heavy chain enhancers.

Authors:  J P Manis; N van der Stoep; M Tian; R Ferrini; L Davidson; A Bottaro; F W Alt
Journal:  J Exp Med       Date:  1998-10-19       Impact factor: 14.307

View more
  4 in total

1.  Homologous elements hs3a and hs3b in the 3' regulatory region of the murine immunoglobulin heavy chain (Igh) locus are both dispensable for class-switch recombination.

Authors:  Yi Yan; Joyce Pieretti; Zhongliang Ju; Shiniu Wei; John R Christin; Fatmata Bah; Barbara K Birshtein; Laurel A Eckhardt
Journal:  J Biol Chem       Date:  2011-06-14       Impact factor: 5.157

2.  Dynamic changes in binding of immunoglobulin heavy chain 3' regulatory region to protein factors during class switching.

Authors:  Sanjukta Chatterjee; Zhongliang Ju; Rabih Hassan; Sabrina A Volpi; Alexander V Emelyanov; Barbara K Birshtein
Journal:  J Biol Chem       Date:  2011-06-17       Impact factor: 5.157

3.  High-affinity IgG antibodies develop naturally in Ig-knockout rats carrying germline human IgH/Igκ/Igλ loci bearing the rat CH region.

Authors:  Michael J Osborn; Biao Ma; Suzanne Avis; Ashleigh Binnie; Jeanette Dilley; Xi Yang; Kevin Lindquist; Séverine Ménoret; Anne-Laure Iscache; Laure-Hélène Ouisse; Arvind Rajpal; Ignacio Anegon; Michael S Neuberger; Roland Buelow; Marianne Brüggemann
Journal:  J Immunol       Date:  2013-01-09       Impact factor: 5.422

4.  A role for the IgH intronic enhancer E mu in enforcing allelic exclusion.

Authors:  Fubin Li; Laurel A Eckhardt
Journal:  J Exp Med       Date:  2008-12-29       Impact factor: 14.307

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.